CLOs on the Move

JenaValve

www.jenavalve.com

 
JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.
  • Number of Employees: 100-250
  • Annual Revenue: $250-500 Million
  • www.jenavalve.com
  • 1000 N. West Street Suite 1200
    Wilmington, DE USA 19801
  • Phone: 302.295.4897

Executives

Name Title Contact Details

Similar Companies

Dental Arts Orthodontic Laboratory

Dental Arts Orthodontic Laboratory is a Anaheim, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Circaid Medical Products Inc

Circaid Medical Products Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Solstice Medical

Solstice Medical is a Fort Wayne, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Integrity Applications

Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea.

MediChair/Medi-E-Ox

MediChair/Medi-E-Ox is a Goderich, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.